As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Cytokine Market: By Type: Tumour Necrosis Factor - TNF, Interleukins - II, Interferons - IFN, Epidermal Growth Factor - EGF, Others; By Therapeutic Application: Cancer, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Cytokine Market Outlook

The global cytokine market is expected to grow in the forecast period of 2021-2026 at a CAGR of 6%.

 

Increasing Prevalence of Diseases, such as Cancer and Skin Disorders Boosting the Industry Growth

Cytokines are known to play an essential role in many disease processes; they can be used in treating many disorders. An individual’s ability to fight off infection can be determined by measuring cytokine production. Cytokine are used as therapeutic agents in treating people with cancer and immunodeficiency disorders and those undergoing organ transplantation. Cytokine can enhance the vaccines’ effectiveness when mixed with a vaccine.  They also act as fighting agents in our bodies. When they are released, they signal the immune system to do its job. Cytokine affects the growth of all blood cells and other cells that help the body's immune and inflammation responses. They also help boost anti-cancer activity in the body by sending signals that can help make abnormal cells die and normal cells live longer.  The increasing prevalence of diseases like cancer and skin disorders is expected to drive the growth of the cytokine industry.

 

Global Cytokine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Cytokine: Industry Definition and Segmentation

Cytokine refers to a group of small, short-lived proteins that are released by one cell to regulate the function of another cell, thereby serving as intercellular chemical messengers. Cytokine effect changes in cellular behaviour that are important in a number of physiological processes, including reproduction, growth and development, and injury repair.

Based on type, the market is divided into:

  • Tumour Necrosis Factor - TNF
  • Interleukins - II
  • Interferons - IFN
  • Epidermal Growth Factor - EGF
  • Others

Based on therapeutic application, the market is divided into:

  • Cancer 
  • Asthma and Airway Inflammation
  • Arthritis
  • Others

The EMR report looks into the regional markets of cytokine like North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

The Advancement of New Technologies to Aid the Growth of Cytokine Industry

Cytokine has proven to be effective in the treatment of cancer and may continue to play a major role in the development of cancer immunotherapy. Cloned cytokine has been used for the treatment of hepatitis C, hepatitis B, and many types of cancer. Cytokine is also effective for the treatment of a rare hereditary disease. Further, cytokines, when released in response to inflammation, infection, and immunity, can help restrict the growth of cancer. The therapeutic application of cytokine in the treatment of cancer is expected to hold the largest share of the market. This could be attributed to the increasing acceptance of cytokine in cancer therapy over the world. Moreover, the cytokine is generally used in R&D activities in the field of drug development and life sciences. The growing demand for cytokine for wound management and cancer therapeutics is expected to drive the growth of the market. The cytokine industry is anticipated to grow over the forecast period owing to the advancement of new technologies.

 

Key Industries Players in the Global Cytokine Market

The report presents a detailed analysis of the following key players in the global cytokine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Lonza Group Ltd.
  • Abcam plc.
  • Genscript Biotech Corporation
  • Randox Laboratories Ltd.
  • Others

The comprehensive report looks into macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Therapeutic Application, Regions
Breakup by Type Tumour Necrosis Factor - TNF, Interleukins - II, Interferons - IFN, Epidermal Growth Factor - EGF, Others
Breakup by Therapeutic Application Cancer, Asthma and Airway Inflammation, Arthritis, Others
Breakup by Regions North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles-Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered F. Hoffmann-La Roche Ltd, Merck KGaA, Lonza Group Ltd, Abcam plc., Genscript Biotech Corporation, Randox Laboratories Ltd., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Cytokine Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Cytokine Historical Market (2016-2020) 
    8.3    Global Cytokine Market Forecast (2021-2026) 
    8.4    Global Cytokine Market by Type
        8.4.1    Tumour Necrosis Factor - TNF
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Interleukins - II
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026) 
        8.4.3    Interferons - IFN
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Epidermal Growth Factor - EGF
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
        8.4.5    Others
    8.5    Global Cytokine Market by Therapeutic Application
        8.5.1    Cancer
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Asthma and Airway Inflammation
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Arthritis
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Others
    8.6    Global Cytokine Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    F. Hoffmann-La Roche Ltd
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Merck KGaA
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Lonza Group Ltd
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Abcam plc.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Genscript Biotech Corporation
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Randox Laboratories Ltd.
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Others
12    Industry Events and Developments


List of Figures and Tables

1.    Global Cytokine Market: Key Industry Highlights, 2016 and 2026
2.    Global Cytokine Historical Market: Breakup by Type (USD Million), 2016-2020
3.    Global Cytokine Market Forecast: Breakup by Type (USD Million), 2021-2026
4.    Global Cytokine Historical Market: Breakup by Therapeutic Application (USD Million), 2016-2020
5.    Global Cytokine Market Forecast: Breakup by Therapeutic Application (USD Million), 2021-2026
6.    Global Cytokine Historical Market: Breakup by Region (USD Million), 2016-2020
7.    Global Cytokine Market Forecast: Breakup by Region (USD Million), 2021-2026
8.    North America Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
9.    North America Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
10.    Europe Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
11.    Europe Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Asia Pacific Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Asia Pacific Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Latin America Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Latin America Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Middle East and Africa Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Middle East and Africa Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Global Cytokine Market Structure

Key Questions Answered in the Report

The global cytokine market is projected to grow at a CAGR of 6% between 2021 and 2026.

The market is driven by the increasing prevalence of diseases such as cancer and skin disorders, growing demand for cytokine for wound management and cancer therapeutics and increasing disposable income.

The market is expected to be defined by the technological advancements in the industry.

The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The different type of cytokine available in the market are tumour necrosis factor – TNF, Interleukins – II, Interferons – IFN, and epidermal growth factor - EGF, among others.

The various therapeutic applications of cytokine is in diseases, such as cancer, asthma and airway inflammation, and arthritis, among others.

The leading players in this market are F. Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Abcam plc, Genscript Biotech Corporation, and Randox Laboratories Ltd., among others.

Analyst Review

The global cytokine market is driven by increasing prevalence of diseases, such as cancer and skin disorders. Aided by the technological advances in the industry, the market is expected to witness a further a growth in the forecast period of 2021-2026, growing at a CAGR of 6%.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. The cytokine industry is divided on the basis of types into  tumour necrosis factor – TNF, Interleukins – II, Interferons – IFN, and epidermal growth factor - EGF, among others. The market is segmented on the basis of therapeutic applications into cancer, asthma and airway inflammation, and arthritis, among others. The key players in the above industry include F. Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Abcam plc, Genscript Biotech Corporation, and Randox Laboratories Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Unna Boot Market Report and Forecast 2021-2026


Global Radiodermatitis Market Report and Forecast 2021-2026


Global Medical Nonwoven Disposables Market Report and Forecast 2021-2026


Global Urinary Drainage Bags Market Report and Forecast 2021-2026


Global Teleradiology Market Report and Forecast 2021-2026


NEWSLETTER